Acorda Therapeutics(ACOR) - 2023 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Title of each class Trading Symbol Name of each exchange on which registered Common Stock $0.001 par value per share ACOR Nasdaq Global Select Market Securities registered pursuant to Section 12(g) of the Act: None ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...